Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives

Treatment of acute myeloid leukemia (AML) has improved in recent years and several new therapeutic options have been approved. Most of them include mutation-specific approaches (e.g., gilteritinib for AML patients with activating <i>FLT3</i> mutations), or are restricted to such defined...

Full description

Saved in:
Bibliographic Details
Main Authors: Maximilian Fleischmann, Ulf Schnetzke, Andreas Hochhaus, Sebastian Scholl
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
AML
Online Access:https://doaj.org/article/92d98bbe561a495e8ea86d12d1f69b9f
Tags: Add Tag
No Tags, Be the first to tag this record!